Literature DB >> 20046468

Red blood cell transfusions in newborn infants: Revised guidelines.

.   

Abstract

In general, health care professionals taking care of high risk infants in neonatal intensive care units have become more restrictive in their use of red blood cell transfusion over the past 10 years. The present statement is intended for those caring for high risk newborn infants (preterm to one month of age). The objectives of this statement are to provide guidelines to reduce the incidence of anemia in preterm and term infants, to identify strategies to decrease the need for red blood cell transfusions and to limit donor exposure in this population. Recommendations for red blood cell transfusions are included.

Entities:  

Keywords:  Anemia; Blood transfusion; Erythrocytes; Erythropoietin; Infant; Newborn; Phlebotomy

Year:  2002        PMID: 20046468      PMCID: PMC2798601          DOI: 10.1093/pch/7.8.553

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN: 1205-7088            Impact factor:   2.253


  59 in total

1.  Randomized trial assessing the feasibility and safety of biologic parents as RBC donors for their preterm infants.

Authors:  R G Strauss; L F Burmeister; K Johnson; G Cress; D G Cordle
Journal:  Transfusion       Date:  2000-04       Impact factor: 3.157

Review 2.  Red blood cell transfusion practices in the neonate.

Authors:  R G Strauss
Journal:  Clin Perinatol       Date:  1995-09       Impact factor: 3.430

Review 3.  Erythropoietin in the pathogenesis and treatment of neonatal anemia.

Authors:  R G Strauss
Journal:  Transfusion       Date:  1995-01       Impact factor: 3.157

4.  Optimizing the approach to anemia in the preterm infant: is there a role for erythropoietin therapy?

Authors:  J Asch; J F Wedgwood
Journal:  J Perinatol       Date:  1997 Jul-Aug       Impact factor: 2.521

Review 5.  Anaemia of prematurity. Epidemiology, management and costs.

Authors:  M P Meyer
Journal:  Pharmacoeconomics       Date:  1997-10       Impact factor: 4.981

6.  Effectiveness of WBC reduction in neonates: what is the evidence of benefit?

Authors:  Dean Fergusson; Paul C Hébert; Keith J Barrington; Stanley H Shapiro
Journal:  Transfusion       Date:  2002-02       Impact factor: 3.157

7.  Recombinant human erythropoietin vs transfusions in the treatment of anemia of prematurity. A cost-benefit analysis.

Authors:  T I Shireman; P E Hilsenrath; R G Strauss; J A Widness; A H Mutnick
Journal:  Arch Pediatr Adolesc Med       Date:  1994-06

8.  Early treatment of premature infants with recombinant human erythropoietin.

Authors:  J Messer; J Haddad; L Donato; D Astruc; J Matis
Journal:  Pediatrics       Date:  1993-10       Impact factor: 7.124

9.  Autologous umbilical cord blood transfusion.

Authors:  A Ballin; E Arbel; G Kenet; M Berar; D Kohelet; A Tanay; H Zakut; D Meytes
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-11       Impact factor: 5.747

10.  Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.

Authors:  K M Shannon; J F Keith; W C Mentzer; R A Ehrenkranz; M S Brown; J A Widness; C A Gleason; E M Bifano; D D Millard; C B Davis
Journal:  Pediatrics       Date:  1995-01       Impact factor: 7.124

View more
  7 in total

1.  Transfusion and risk of infection in Canada: Update 2006.

Authors: 
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-03       Impact factor: 2.471

Review 2.  Nonpharmacological, blood conservation techniques for preventing neonatal anemia--effective and promising strategies for reducing transfusion.

Authors:  Patrick D Carroll; John A Widness
Journal:  Semin Perinatol       Date:  2012-08       Impact factor: 3.300

3.  Red blood cell transfusion in newborn infants.

Authors:  Robin K Whyte; Ann L Jefferies
Journal:  Paediatr Child Health       Date:  2014-04       Impact factor: 2.253

4.  Transfusion and risk of infection in Canada: Update 2012.

Authors:  Noni E Macdonald; Sheila F O'Brien; Gilles Delage
Journal:  Paediatr Child Health       Date:  2012-12       Impact factor: 2.253

5.  Gentamicin in neonates at risk for sepsis - peak serum concentrations are not necessary.

Authors:  Luke F Reynolds; Timothy L Mailman; Douglas D McMillan
Journal:  Paediatr Child Health       Date:  2012-06       Impact factor: 2.253

6.  Transfusion support in preterm neonates <1500 g and/or <32 weeks in a tertiary care center: A descriptive study.

Authors:  R A Shanmugha Priya; R Krishnamoorthy; Vinod Kumar Panicker; Binu Ninan
Journal:  Asian J Transfus Sci       Date:  2018 Jan-Jun

7.  Transfusion rates and disease spectrum in neonates treated with blood transfusion in China.

Authors:  Yang Sun; Ting Ma; Wen-Hua Wang; Qin Zhang; Zhen-Ai Jin; Jiang-Cun Yang
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.